Qube Research & Technologies (QRT)
TLSI icon

Qube Research & Technologies (QRT)’s TriSalus Life Sciences TLSI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,490
Closed -$53.5K – 4711
2024
Q1 		$53.5K Buy
+5,490
New +$50.7K ﹤0.01% 3489

Other funds holding TLSI

DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CWM
Connecticut Wealth Management Farmington, Connecticut $2.39B AUM 17.35% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TLSI Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of TriSalus Life Sciences (TLSI) in Q2 2024, closing a stake of 5,490 shares — an estimated $53.5K sold.

Qube Research & Technologies (QRT) first reported a position in TLSI in Q1 2024 and held it in 1 quarter. The position peaked at $53.5K in Q1 2024. 28 funds tracked by Wall St. Rank hold TLSI as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining TriSalus Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5,490 TriSalus Life Sciences shares in Q2 2024, an estimated $53.5K.
  • Qube Research & Technologies (QRT) first reported a position in TriSalus Life Sciences in Q1 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s TriSalus Life Sciences position peaked at $53.5K in Q1 2024.
  • 28 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.